Inventor · disambiguated record
Eric Tartour
Also filed as: TARTOUR ERIC
5 granted patents·12 pending applications·45 citations·filing 2003–2022
78Inventor score
Files withINST CURIE6CYTUNE PHARMA2TARTOUR ERIC2HRA PHARMA LAB1INSERM (INSTITUT NAT DE LA SANTE ET DE LARECHERCHE MEDICALE)1
Top patents by PatentIndex Score
17 records- 0188US8685408B2Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cellsTARTOUR ERIC·Filed 2007·Granted Apr 1, 2014·30 cites·24 claims
- 0283US7632514B2Universal carrier for targeting molecules to Gb3 receptor expressing cellsINST CURIE·Filed 2003·Granted Dec 15, 2009·11 cites·11 claims
- 0379US8852612B2Universal carrier for targeting molecules to Gb3 receptor expressing cellsJOHANNES LUDGER·Filed 2009·Granted Oct 7, 2014·2 cites·11 claims
- 0471US11273204B2IL-15 and IL-15RAPLHA sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2014·Granted Mar 15, 2022·2 cites·7 claims
- 0568US9603923B2Universal carrier for targeting molecules to GB3 receptor expressing cellsINST CURIE·Filed 2014·Granted Mar 28, 2017·0 cites·11 claims
- 0659US2022193199A1Il-15 and il-15ralpha sushi domain based modulokinesCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 0758US2014205630A1Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cellsUNIV PARIS DESCARTES·Filed 2014·Application pending·0 cites
- 0854US2019201480A1Combined vaccination/radioterapy for cancer treatmentINST CURIE·Filed 2019·Application pending·0 cites
- 0951US2023266332A1Methods and compositions for preventing and treating a cancerINSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE·Filed 2021·Application pending·0 cites
- 1051US2017042994A1Compositions having means for targeting at least one antigen to dendritic cellsINST CURIE·Filed 2016·Application pending·0 cites
- 1147US2022107323A1Methods and compositions for identifying whether a subject suffering from a cancer will achieve a response with an immune-checkpoint inhibitorINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1246US2024033366A1FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOFINST CURIE·Filed 2021·Application pending·0 cites
- 1345US2010138938A1Method of producing a multichimeric mouse and applications to study the immunopathogenesis of human tissue-specific pathologiesPASTEUR INSTITUT·Filed 2007·Application pending·0 cites
- 1445US2018036368A1Combined vaccination/radioterapy for cancer treatmentINST CURIE·Filed 2016·Application pending·0 cites
- 1543US2014199379A1Compositions having means for targeting at least one antigen to dendritic cellsTARTOUR ERIC·Filed 2012·Application pending·0 cites
- 1642US2021317165A1Zp3 fragments in immunotherapy of ovarian cancerHRA PHARMA LAB·Filed 2019·Application pending·0 cites
- 1728US2020264165A1Use of pd-1 and tim-3 as a measure for cd8+ cells in predicting and treating renal cell carcinomaINSERM (INSTITUT NAT DE LA SANTE ET DE LARECHERCHE MEDICALE)·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Tartour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →